Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

TC-1734: an orally active neuronal nicotinic acetylcholine receptor modulator with antidepressant, neuroprotective and long-lasting cognitive effects.

Gatto GJ, Bohme GA, Caldwell WS, Letchworth SR, Traina VM, Obinu MC, Laville M, Reibaud M, Pradier L, Dunbar G, Bencherif M.

CNS Drug Rev. 2004 Summer;10(2):147-66. Review.

2.

Nicotinic receptor subtypes and cognitive function.

Levin ED.

J Neurobiol. 2002 Dec;53(4):633-40. Review.

4.

Nicotinic acetylcholine involvement in cognitive function in animals.

Levin ED, Simon BB.

Psychopharmacology (Berl). 1998 Aug;138(3-4):217-30. Review.

PMID:
9725745
5.

ABT-089: pharmacological properties of a neuronal nicotinic acetylcholine receptor agonist for the potential treatment of cognitive disorders.

Rueter LE, Anderson DJ, Briggs CA, Donnelly-Roberts DL, Gintant GA, Gopalakrishnan M, Lin NH, Osinski MA, Reinhart GA, Buckley MJ, Martin RL, McDermott JS, Preusser LC, Seifert TR, Su Z, Cox BF, Decker MW, Sullivan JP.

CNS Drug Rev. 2004 Summer;10(2):167-82. Review.

6.

Nicotinic actions on neuronal networks for cognition: general principles and long-term consequences.

Poorthuis RB, Goriounova NA, Couey JJ, Mansvelder HD.

Biochem Pharmacol. 2009 Oct 1;78(7):668-76. doi: 10.1016/j.bcp.2009.04.031. Epub 2009 May 6. Review.

PMID:
19426718
7.

Neurotrophic effects of central nicotinic receptor activation.

Belluardo N, Mudo G, Blum M, Amato G, Fuxe K.

J Neural Transm Suppl. 2000;(60):227-45. Review.

PMID:
11205143
8.

Nicotinic-antipsychotic drug interactions and cognitive function.

Levin ED, Rezvani AH.

EXS. 2006;98:185-205. Review.

PMID:
17019889
9.

Nicotinic receptors in aging and dementia.

Picciotto MR, Zoli M.

J Neurobiol. 2002 Dec;53(4):641-55. Review.

10.

Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization.

Levin ED, McClernon FJ, Rezvani AH.

Psychopharmacology (Berl). 2006 Mar;184(3-4):523-39. Epub 2005 Oct 12. Review.

PMID:
16220335
11.

The potential of subtype-selective neuronal nicotinic acetylcholine receptor agonists as therapeutic agents.

Lloyd GK, Menzaghi F, Bontempi B, Suto C, Siegel R, Akong M, Stauderman K, Velicelebi G, Johnson E, Harpold MM, Rao TS, Sacaan AI, Chavez-Noriega LE, Washburn MS, Vernier JM, Cosford ND, McDonald LA.

Life Sci. 1998;62(17-18):1601-6. Review.

PMID:
9585143
12.

An overview of SSR149415, a selective nonpeptide vasopressin V(1b) receptor antagonist for the treatment of stress-related disorders.

Serradeil-Le Gal C, Wagnon J 3rd, Tonnerre B, Roux R, Garcia G, Griebel G, Aulombard A.

CNS Drug Rev. 2005 Spring;11(1):53-68. Review.

13.
14.

Long-lasting cognitive improvement with nicotinic receptor agonists: mechanisms of pharmacokinetic-pharmacodynamic discordance.

Buccafusco JJ, Letchworth SR, Bencherif M, Lippiello PM.

Trends Pharmacol Sci. 2005 Jul;26(7):352-60. Review.

PMID:
15946748
15.

Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine.

Wang R, Yan H, Tang XC.

Acta Pharmacol Sin. 2006 Jan;27(1):1-26. Review.

16.

Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics.

Decker MW, Brioni JD, Bannon AW, Arneric SP.

Life Sci. 1995;56(8):545-70. Review.

PMID:
7869835
17.

Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms.

Mudo G, Belluardo N, Fuxe K.

J Neural Transm (Vienna). 2007 Jan;114(1):135-47. Epub 2006 Aug 17. Review.

PMID:
16906354
18.

Targeting neuronal nicotinic receptors: a path to new therapies.

Bencherif M, Schmitt JD.

Curr Drug Targets CNS Neurol Disord. 2002 Aug;1(4):349-57. Review.

PMID:
12769609
19.

TC-5214 (S-(+)-mecamylamine): a neuronal nicotinic receptor modulator with antidepressant activity.

Lippiello PM, Beaver JS, Gatto GJ, James JW, Jordan KG, Traina VM, Xie J, Bencherif M.

CNS Neurosci Ther. 2008 Winter;14(4):266-77. doi: 10.1111/j.1755-5949.2008.00054.x. Review.

PMID:
19040552
20.

Nicotine and neurodegeneration in ageing.

Zanardi A, Leo G, Biagini G, Zoli M.

Toxicol Lett. 2002 Feb 28;127(1-3):207-15. Review.

PMID:
12052660

Supplemental Content

Support Center